Wikidata

(Q34440364)

English

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

scientific article

In more languages

Statements

title
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
author name string
Maloney DG
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Grillo-López AJ
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Schilder RJ
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Neidhart JA
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Janakiraman N
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Dallaire BK
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
Royston I
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
publication date
1 September 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017
page(s)
2188-2195
1 reference
stated in
Europe PubMed Central
PubMed ID
9310469
retrieved
2 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34440364&oldid=1951079470"